Publications

5543 Results

Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203

Authors
M Zhang;M Othus;K McMillen;H Erba;G Garcia-Manero;J Pagel;M Sorror;M Percival
Journal / Conference
Leukemia Jul;38(7):1488-1493
Year
2024
Research Committee(s)
Leukemia
PMID
PMID38830960
Study Number(s)
S1203

Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial

Authors
S Gulati;C Tangen;C Ryan;U Vaishampayan;B Shuch;P Barata;D Pruthi;C Bergerot;A Tripathi;S Lerner;I Thompson;P Lara;S Pal
Journal / Conference
JAMA Network Open Aug 1;7(8):e2425288
Year
2024
Research Committee(s)
Genitourinary
PMID
PMID39106067
PMC
PMC11304111
Study Number(s)
S0931

Postoperative Adverse Events Following Neoadjuvant Therapy and Surgery in a Phase 2 Borderline Resectable Pancreatic Cancer Clinical Trial (Alliance A021501)

Authors
R Snyder;T Zemla;Q Shi;D Segovia;S Ahmad;E O'Reilly;J Herman;M Katz
Journal / Conference
Annals of Surgical Oncology Jul 15. doi: 10.1245/s10434-024-15670-6. Online ahead of print
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID39008208
Study Number(s)
CTSU/A021501

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Authors
F Battaglin;Y Baca;J Millstein;J Xiu;Y Arai;J Wang;F Ou;F Innocenti;P Jayachandran;N Kawanishi;A Lenz;S Soni;S Algaze;W Zhang;Y Yang;A Seeber;J Abraham;E Lou;PA Philip;B Weinberg;AF Shields;R Goldberg;J Marshall;A Venook;W Korn;H-J Lenz
Journal / Conference
Journal for ImmunoTherapy of Cancer Jan 11;12(1):e007939
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID38212126
PMC
PMC10806545
Study Number(s)
CTSU/C80405

HER2 gene expression levels are predictive and prognostic in patients with metastatic colorectal cancer enrolled in CALGB/SWOG 80405

Authors
F Battaglin;F Ou;X Qu;M Bertagnolli;H Hochster;D Niedzwiecki;R Goldberg;R Mayer;K Ashouri;T Zemla;CD Blanke;A Venook;O Kabbarah;H-J Lenz;F Innocenti
Journal / Conference
Journal of Clinical Oncology Jun 1;42(16):1890-1902
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID38457761
PMC
PMC11240881
Study Number(s)
CTSU/C80405

Improved survival with adjuvant COX-2 inhibition in PIK3CA-activated stage III colon cancer

Authors
J Nowak;T Twombly;C Ma;Q Shi;K Haruki;K Fujiyoshi;J Vayrynen;M Zhao;J Knight;S Mane;P Kumar;F Couture;P Kuebler;S Krishnamurthi;B Tan;P Philip;E O'Reilly;A Shields;S Ogino;C Fuchs;J Meyerhardt
Journal / Conference
Journal of Clinical Oncology Aug 20;42(24):2853-2859
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID38889377
Study Number(s)
CTSU/C80702

Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer

Authors
S Kircher;F Duan;N An;I Gareen;J Sicks;G Sadigh;J Suga;H Kean;P Mehan;R Bajaj;J Acoba;D Hanson;S Dalia;D Gokalp Yasar;E Park;L Wagner;R Carlos
Journal / Conference
JAMA Network Open Jan 2;7(1):e2350844
Year
2024
Research Committee(s)
Cancer Care Delivery
PMID
PMID38194233
PMC
PMC10777253

q-Diffusion leverages the full dimensionality of gene coexpression in single-cell transcriptomics

Authors
M Marmarelis;N Singh;R Littman;F Battaglin;J Ambite;A Galstyan;H-J Lenz;G Ver Steeg
Journal / Conference
Communications Biology Apr 2;7(1):400
Year
2024
Research Committee(s)
Gastrointestinal
PMID
PMID38565955
PMC
PMC11255321
Study Number(s)
CTSU/C80405

A randomized phase III double-blind placebo-controlled trial of first line chemotherapy and trastuzumab with or without bevacizumab for patients with HER2/neu over-expressing metastatic breast cancer: a trial of the ECOG-ACRIN Cancer Research Group (E1105)

Authors
J Mezzanotte-Sharpe;A O'Neill;I Mayer;C Arteaga;X Yang;L Wagner;D Celia;N Meropol;R Alpaugh;T Saphner;R Swaney;K Hoelzer;W Gradishar;V Abramson;K Sundaram;S Jilani;E Perez;N Lin;M Jahanzeb;G Sledge;S Reid
Journal / Conference
Breast Cancer Research and Treatment Sep;207(2):275-282
Year
2024
Research Committee(s)
Breast
PMID
PMID38967884
PMC
PMC11297090
Study Number(s)
CTSU/E1105

Phase II Trial of Afatinib in Patients With EGFR-Mutated Solid Tumors Excluding Lung Cancer: Results From NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol A

Authors
S Gettinger;Z Song;K Reckamp;J Moscow;R Gray;V Wang;L McShane;L Rubinstein;D Patton;P Willams;S Hamilton;X Kong;J Tricoli;B Conley;C Arteaga;L Harris;P O'Dwyer;A Chen;K Flaherty
Journal / Conference
JCO Precision Oncology Jul:8:e2300725
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID38986051
Study Number(s)
CTSU/EAY131